title: Long term outcome of patients with steroid-refractory acute intestinal graft versus host disease after treatment with pentostatin.
authors.forename: Stefan A
authors.initials: SA
authors.lastname: Klein
authors.forename: Gesine
authors.initials: G
authors.lastname: Bug
authors.forename: Sabine
authors.initials: S
authors.lastname: Mousset
authors.forename: Wolf-Karsten
authors.initials: WK
authors.lastname: Hofmann
authors.forename: Dieter
authors.initials: D
authors.lastname: Hoelzer
authors.forename: Hans
authors.initials: H
authors.lastname: Martin
mesh_terms: D000208:Acute Disease; D058892:Adenosine Deaminase Inhibitors / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy*; D019337:Hematologic Neoplasms / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D015649:Pentostatin / Q000627:therapeutic use*; D036102:Peripheral Blood Stem Cell Transplantation; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D058892:Adenosine Deaminase Inhibitors; D007166:Immunosuppressive Agents; D015649:Pentostatin